Literature DB >> 26509221

VISION-RELATED QUALITY OF LIFE AND VISUAL FUNCTION AFTER RETINAL DETACHMENT SURGERY.

Eva Smretschnig1, Christiane I Falkner-Radler, Susanne Binder, Jessica Spörl, Robin Ristl, Carl Glittenberg, Katharina Krepler.   

Abstract

PURPOSE: To investigate and compare the vision-related quality of life after rhegmatogenous retinal detachment (RRD) surgery with that of normal controls and to evaluate the relationship between the vision-related quality of life and visual function after surgery for RRD.
METHODS: In this prospective, consecutive, comparative case series, the 25-Item National Eye Institute Visual Function Questionnaire (NEI-VFQ-25) was completed by 100 RRD patients at 6 months after surgery. Among the patients with RRD, 86 underwent pars plana vitrectomy and 14 received scleral buckling. Best-corrected visual acuity was obtained using ETDRS charts and converted to the logarithm of the minimum angle of resolution for statistical calculations. The VFQ-25 also was administered to 107 normal controls.
RESULTS: The VFQ-25 composite score and the subscales associated with general vision, mental health, social functioning, driving, and color vision were significantly lower in the RRD group than in the normal controls (P < 0.05). The VFQ-25 composite score significantly correlated with logarithm of the minimum angle of resolution best-corrected visual acuity (P < 0.0001) on both the operated and the fellow eye.
CONCLUSION: The vision-related quality of life is significantly impaired in patients after surgery for RRD. Higher age and female gender negatively influences the results of the composite score.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 26509221     DOI: 10.1097/IAE.0000000000000817

Source DB:  PubMed          Journal:  Retina        ISSN: 0275-004X            Impact factor:   4.256


  7 in total

1.  Vision-Related Functioning in Patients Undergoing Pneumatic Retinopexy vs Vitrectomy for Primary Rhegmatogenous Retinal Detachment: A Post Hoc Exploratory Analysis of the PIVOT Randomized Clinical Trial.

Authors:  Rajeev H Muni; Carolina L M Francisconi; Tina Felfeli; Michael Y K Mak; Alan R Berger; David T Wong; Filiberto Altomare; Louis R Giavedoni; Radha P Kohly; Peter J Kertes; Natalia Figueiredo; Fei Zuo; Kevin E Thorpe; Roxane J Hillier
Journal:  JAMA Ophthalmol       Date:  2020-08-01       Impact factor: 7.389

Review 2.  Patient-reported outcome measures in vitreoretinal surgery: a systematic review.

Authors:  Anusha Yoganathan; Teresa Sandinha; Mohith Shamdas; Asterios Diafas; David Steel
Journal:  Eye (Lond)       Date:  2022-05-12       Impact factor: 3.775

3.  A quality of life study comparing scleral buckle and pneumatic retinopexy for the treatment of rhegmatogenous retinal detachment.

Authors:  Angela C Gauthier; Ron A Adelman
Journal:  Clin Ophthalmol       Date:  2017-06-06

4.  ROCK inhibition reduces morphological and functional damage to rod synapses after retinal injury.

Authors:  Éva Halász; Marco A Zarbin; Amy L Davidow; Laura J Frishman; Peter Gombkoto; Ellen Townes-Anderson
Journal:  Sci Rep       Date:  2021-01-12       Impact factor: 4.379

5.  Visual Acuity Inadequately Reflects Vision-Related Quality of Life in Patients After Macula-Off Retinal Detachment Surgery.

Authors:  Heijan Ng; Koenraad A Vermeer; Jan C van Meurs; Ellen C La Heij
Journal:  Invest Ophthalmol Vis Sci       Date:  2020-08-03       Impact factor: 4.799

6.  APPLICATION OF MODIFIED NEI VFQ-25 AFTER RETINAL DETACHMENT TO VISION-RELATED QUALITY OF LIFE.

Authors:  Jelena Potic; Ciara Bergin; Clarice Giacuzzo; Lazaros Konstantinidis; Alejandra Daruich; Thomas J Wolfensberger
Journal:  Retina       Date:  2021-03-01       Impact factor: 3.975

7.  Microperimetry-Assessed Functional Alterations and OCT-Changes in Patients after Retinal Detachment Surgery Using Pars Plana Vitrectomy and SF6 Tamponade.

Authors:  María D Díaz-Barreda; Isabel Bartolomé-Sesé; Ana Boned-Murillo; Antonio Ferreras; Elvira Orduna-Hospital; Francisco J Ascaso; Isabel Pinilla
Journal:  Diagnostics (Basel)       Date:  2021-06-24
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.